AnaptysBio Inc buy Guggenheim
Start price
05.11.25
/
50%
€31.20
Target price
05.11.26
€87.01
Performance (%)
34.62%
Price
18.12.25
€40.80
Summary
This prediction is currently active. With a performance of 34.62% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 05.11.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 7.368% | 7.368% |
| iShares Core DAX® | 0.299% | 4.394% |
| iShares Nasdaq 100 | 0.666% | 1.175% |
| iShares Nikkei 225® | -0.656% | -0.055% |
| iShares S&P 500 | 0.352% | 1.378% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio (NASDAQ:ANAB) had its price target raised by analysts at Guggenheim from $90.00 to $100.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat